The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinational
drugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size and
its reliance on out-of-pocket payments highlight the challenges it poses. Moreover, continued economic
weakness and negative demographic trends will limit growth prospects.
Headline Expenditure Projections
? Pharmaceuticals: MDL5.83bn (USD310mn) in 2015 to MDL6.23bn (USD322mn) in 2016; 6.7% in
local currency terms and 3.8% in US dollar terms. Forecast unchanged from previous quarter.
? Healthcare: MDL12.32bn (USD654mn) in 2015 to MDL13.27bn (USD686mn) in 2015; +7.7% in local
currency terms and 4.8% in US dollar terms. Forecast unchanged from previous quarter.